PerkinElmer

NYSE
PKI
Stock
Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

PerkinElmer

120.00120.0090.0090.0060.0060.0030.0030.000.000.00Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
5/10
30.7 52.65 -41.69% 32.19 -4.62%
P/S 5.37 4.03 33.12%
P/BV 2.4 10.87 -77.87%
P/FCF 28.54 39.64 -27.99%
Ev/Ebitda 18.26 16.12 13.33%
Ev/S 6.61 4.35 51.98%
Ev/FCF 36.84 52.31 -29.57%
E/P 0.0342 0.2095 -83.67%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
36.21 19.07 89.86% 33.96 +6.63%
ROE 7.98 -83.32 -109.57%
ROA 3.97 6.38 -37.69%
ROIC 8.67 15.06 -42.43%
ROS 17.5 9.34 87.46%
ROCE 10.04 67.03 -85.02%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
3/10
3.8 1.02 273.61% 3.64 +4.62%
Nеt Debt/Ebitda 3.43 1.4 145.05%
Debt/Ratio 0.3227 0.2741 17.74%
Debt/Equity 0.9095 13.6 -93.31%
Debt/Net Income 7.87 6.8 15.8%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.28 -100% 0.2136 -100%
Number of years of dividend growth 0 6.75 -100%
DSI 0.7857 0.7413 5.99%
Average dividend growth -25 -4.1 509.16%
Average percentage for 5 years 0.2136 1.34 -84%
Average percentage for payments 31.16 44.08 -29.33%
Difference from average difference in sector -1.28

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
3/10
16.67 12.47 33.68%
Growth impulse Ebitda in 5 years 77.83 -86.3 -190.19%
Growth impulse Net Income in 5 years 74.38 -75.86 -198.05%
Growth impulse FCF in 5 years 33.53 -79.28 -142.29%
Growth impulse EPS in 5 years 53.92 4.34 1142.4%
IP Score
4.67/10

Similar companies

UnitedHealth Group

Humana

Bristol-Myers

Johnson & Johnson

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription